Evidence Report/technology Assessment
Overview
Evidence Report/technology Assessment is a scientific journal, published since 1999 in English. The journal's country of origin is United States.
Details
Details
Abbr.
Evid Rep Technol Assess (Full Rep)
Start
1999
End
2016
p-ISSN
1530-4396
Country
United States
Language
English
Recent Articles
21.
Williams J, Jackson G, Powers B, Chatterjee R, Bettger J, Kemper A, et al.
Evid Rep Technol Assess (Full Rep)
. 2014 Jan;
(208.2):1-210.
PMID: 24422946
Objectives: As part of the Closing the Quality Gap: Revisiting the State of the Science series of the Agency for Healthcare Research and Quality (AHRQ), this systematic review sought to...
22.
Hussey P, Mulcahy A, Schnyer C, Schneider E
Evid Rep Technol Assess (Full Rep)
. 2014 Jan;
(208.1):1-155.
PMID: 24422914
Background: "Bundled payment" is a method in which payments to health care providers are related to the predetermined expected costs of a grouping, or "bundle," of related health care services....
23.
Timbie J, Ringel J, Fox D, Waxman D, Pillemer F, Carey C, et al.
Evid Rep Technol Assess (Full Rep)
. 2014 Jan;
(207):1-305.
PMID: 24422904
Objectives: This systematic review sought to identify the best available evidence regarding strategies for allocating scarce resources during mass casualty events (MCEs). Specifically, the review addresses the following questions: (1)...
24.
Finkelstein J, Knight A, Marinopoulos S, Gibbons M, Berger Z, Aboumatar H, et al.
Evid Rep Technol Assess (Full Rep)
. 2014 Jan;
(206):1-1531.
PMID: 24422882
Objectives: The main objective of the report is to review the evidence on the impact of health information technology (IT) that supports patient-centered care (PCC) on: health care processes; clinical...
25.
Hui C, Neto G, Tsertsvadze A, Yazdi F, Tricco A, Tsouros S, et al.
Evid Rep Technol Assess (Full Rep)
. 2014 Jan;
(205):1-297.
PMID: 24422856
Objectives: To review the evidence for diagnostic accuracy of screening for serious bacterial illness (SBI) and invasive herpes simplex virus (HSV) infection in febrile infants 3 months or younger; ascertain...
26.
Ip S, Dahabreh I, Chung M, Yu W, Balk E, Iovin R, et al.
Evid Rep Technol Assess (Full Rep)
. 2012 Nov;
(204):1-341.
PMID: 23126653
Background: Radical prostatectomy and radiation therapy for prostate cancer have side effects and unclear survival benefits for early stage and low-risk disease. Prostate cancer often has an indolent natural history,...
27.
Lobach D, Sanders G, Bright T, Wong A, Dhurjati R, Bristow E, et al.
Evid Rep Technol Assess (Full Rep)
. 2012 Nov;
(203):1-784.
PMID: 23126650
Objectives: To catalogue study designs used to assess the clinical effectiveness of CDSSs and KMSs, to identify features that impact the success of CDSSs/KMSs, to document the impact of CDSSs/KMSs...
28.
Olson D, Bettger J, Alexander K, Kendrick A, Irvine J, Wing L, et al.
Evid Rep Technol Assess (Full Rep)
. 2012 Nov;
(202):1-197.
PMID: 23126647
Objectives: To review the available published literature to assess whether evidence supports a beneficial role for coordinated transition of care services for the postacute care of patients hospitalized with first...
29.
McKibbon K, Lokker C, Handler S, Dolovich L, Holbrook A, OReilly D, et al.
Evid Rep Technol Assess (Full Rep)
. 2012 Nov;
(201):1-951.
PMID: 23126642
Objectives: The objective of the report was to review the evidence on the impact of health information technology (IT) on all phases of the medication management process (prescribing and ordering,...
30.
Hempel S, Newberry S, Ruelaz A, Wang Z, Miles J, Suttorp M, et al.
Evid Rep Technol Assess (Full Rep)
. 2012 Nov;
(200):1-645.
PMID: 23126627
Objectives: To catalog what is known about the safety of interventions containing Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, and/or Bacillus strains used as probiotic agents in research to reduce the risk...